Pharmaceuticals(52)

  • Search Engine for New Anti-Cancer Targets (No. T4-2090)

    Many newly developed anti-cancer treatments rely on identifying cancer unique signatures that can be used to harness the immune system against the tumor. ... Read more
    Senior Scientist Yifat Merbl

    Yifat Merbl

    Faculty of Biology

    6011
  • Single-Cell Analysis to Enhance Multiple Myeloma Prognostics (No. T4-2075)

    Multiple myeloma (MM) is an incurable malignancy, and despite novel anti-myeloma drugs that increased survival, up to 30% of patients develop primary resistance, and many patients experience early relapse. ... Read more
    Associate Professor Ido Amit

    Ido Amit

    Faculty of Biology

    6019
  • Novel Targets for Treating Acute Liver Failure (ALF) (No. T4-2071)

    Acute liver failure (ALF) is a rapid deterioration of liver function, resulting in a high mortality rate in the absence of liver transplantation. ALF treatment remains highly limited and mostly supportive due to a lack of a comprehensive understanding of the molecular base of ALF. ... Read more
    Associate Professor Eran Elinav

    Eran Elinav

    Faculty of Biology

    6091
  • Treatment for Ewing Sarcoma Using ETS Proteins (No. T4-2068)

    Ewing sarcoma (ES) is a common bone malignancy in children and young adolescents which is usually treated by systemic chemotherapy. In about 25% of the cases, cancer has already spread to other parts of the body at the time of diagnosis. ... Read more
    Extension Service Yosef Yarden

    Yosef Yarden

    Faculty of Biology

    6154
  • Inhibitory Proteins for 20S Proteasome Regulation as Cancer Treatment (No. T4-2065)

    Proteasomal protein degradation is crucial in maintaining cellular integrity and in regulating key cellular processes including cell cycle, proliferation and cell death. ... Read more
    Associate Professor Michal Sharon

    Michal Sharon

    Faculty of Biochemistry

    6139
  • Peptides for Treating Alzheimer's Disease (No. T4-2057)

    Alzheimer's Disease (AD) is an age-associated neurodegenerative disorder characterized clinically by a decline in cognitive function. It is the most common type of dementia, with 5.8 million Americans living with AS in 2020. ... Read more
    Full Professor Ruth Arnon

    Ruth Arnon

    Faculty of Biology

    6160
  • A Novel Opto-Genetic Tool for Light Activated Synaptic Silencing (No. T4-2046)

    Defects in neurotransmitters are associated with several neurological diseases such as Parkinson’s disease, epilepsy, and psychiatric disorders. Optogenetics is a technology based on light-sensitive proteins for optical control of cellular processes. ... Read more
    Prof Ofer Yizhar

    Ofer Yizhar

    Faculty of Biology

    6229
  • Covalent Chemistry Platform for Diagnostics and Drug Discovery (No. T4-2045)

    delivery and activation of drugs or probes is of great importance in therapeutics, diagnostics, and research. For instance, selective delivery/activation of anti-cancer drugs to tumor cells is crucial for their efficacy and reduced side effects. ... Read more
    Senior Scientist Nir London

    Nir London

    Faculty of Chemistry

    6106
  • Treating Chronic Pain by Inhibiting Importin Alpha 3 (No. T4-2040)

    Pain, particularly in cases of chronic nerve injury and disease, is a critical element of numerous medical conditions and procedures, which is generally managed with opioid analgesics. ... Read more
    Full Professor Michael Fainzilber

    Michael Fainzilber

    Faculty of Biochemistry

    6118
  • Circulating microRNA as a Biomarker for ALS Progression (No. T4-2038)

    Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder of the human motor neuron system, for which no effective treatment exists. ... Read more
    Associate Professor Eran Hornstein

    Eran Hornstein

    Faculty of Biochemistry

    6115

Pages

Subscribe to Pharmaceuticals